Infrastructure Capital Advisors, LLC Aurinia Pharmaceuticals Inc. Transaction History

Infrastructure Capital Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$10.93 - $23.55 $251,390 - $541,650	-23,000 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$10.0 - $14.52 $230,000 - $333,960	23,000 New	23,000 $298,000
Q2 2018 Aug 14, 2018	SELL	$5.06 - $6.36 $111,335 - $139,939	-22,003 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$4.85 - $5.99 $13,094 - $16,173	2,700 Added 13.99%	22,003 $114,000
Q4 2017 Feb 13, 2018	BUY	$4.53 - $7.09 $87,442 - $136,858	19,303 New	19,303 $87,000
Q3 2017 Nov 13, 2017	SELL	$5.71 - $6.9 $94,945 - $114,733	-16,628 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	16,628	16,628 $102,000

214

58.3M

1.14M

1.51M

Ticker AUPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,892,000
Market Cap $1.14B
Description
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...

Get notified when there are updates to the investment portfolio of Infrastructure Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Infrastructure Capital Advisors, LLC with notifications on news.